Home

Claudine Bruck

CIK 1733680 · last filed 2025-11-12

Claudine Bruck is a corporate insider who has filed 17 SEC Form 4 insider transactions across 2 companies since 2018. The most recent filing shows the insider exercised options covering $1000 of ANVS on Nov 12, 2025. Across all open-market trades the lifetime net is +$14.7K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $23.2K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$23.2K

Companies

2

Total Filings

17

Lifetime Open-Market Net

$14.7K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ANVS Director 13,709 $1.69 $23.2K $9.8K 11 2025-11-12
NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted Director 16,519 $0.00 $2 $4.9K 6 2021-07-07

Recent Filings

17 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2025-11-12 ANVS Exer (M) +7,142 $1000 EDGAR
2024-07-03 ANVS Grant (A) — $0 EDGAR
2023-11-22 ANVS Other (J) — $0 EDGAR
2023-11-21 ANVS Grant (A) +1,000 $6.1K EDGAR
2023-04-11 ANVS Grant (A) +500 $6.3K EDGAR
2023-01-20 ANVS Grant (A) — $0 EDGAR
2022-01-05 ANVS Grant (A) — $0 EDGAR
2021-10-13 ANVS Buy (P) +181 $5.0K EDGAR
2021-07-09 ANVS Grant (A) — $0 EDGAR
2021-07-07 NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted Grant (A) +3,969 $0 EDGAR
Showing 1–10 of 17
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.